These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
194 related articles for article (PubMed ID: 9927662)
1. Similarity in the catalysis of DNA breakage and rejoining by type IA and IIA DNA topoisomerases. Liu Q; Wang JC Proc Natl Acad Sci U S A; 1999 Feb; 96(3):881-6. PubMed ID: 9927662 [TBL] [Abstract][Full Text] [Related]
2. Toprim--a conserved catalytic domain in type IA and II topoisomerases, DnaG-type primases, OLD family nucleases and RecR proteins. Aravind L; Leipe DD; Koonin EV Nucleic Acids Res; 1998 Sep; 26(18):4205-13. PubMed ID: 9722641 [TBL] [Abstract][Full Text] [Related]
3. A novel and unified two-metal mechanism for DNA cleavage by type II and IA topoisomerases. Schmidt BH; Burgin AB; Deweese JE; Osheroff N; Berger JM Nature; 2010 Jun; 465(7298):641-4. PubMed ID: 20485342 [TBL] [Abstract][Full Text] [Related]
4. Structural basis for gate-DNA recognition and bending by type IIA topoisomerases. Dong KC; Berger JM Nature; 2007 Dec; 450(7173):1201-5. PubMed ID: 18097402 [TBL] [Abstract][Full Text] [Related]
5. Identification of active site residues in the "GyrA" half of yeast DNA topoisomerase II. Liu Q; Wang JC J Biol Chem; 1998 Aug; 273(32):20252-60. PubMed ID: 9685374 [TBL] [Abstract][Full Text] [Related]
6. Identification of active site residues in Escherichia coli DNA topoisomerase I. Chen SJ; Wang JC J Biol Chem; 1998 Mar; 273(11):6050-6. PubMed ID: 9497321 [TBL] [Abstract][Full Text] [Related]
7. Site-directed mutagenesis of conserved aspartates, glutamates and arginines in the active site region of Escherichia coli DNA topoisomerase I. Zhu CX; Roche CJ; Papanicolaou N; DiPietrantonio A; Tse-Dinh YC J Biol Chem; 1998 Apr; 273(15):8783-9. PubMed ID: 9535856 [TBL] [Abstract][Full Text] [Related]
8. Investigating mycobacterial topoisomerase I mechanism from the analysis of metal and DNA substrate interactions at the active site. Cao N; Tan K; Annamalai T; Joachimiak A; Tse-Dinh YC Nucleic Acids Res; 2018 Aug; 46(14):7296-7308. PubMed ID: 29905859 [TBL] [Abstract][Full Text] [Related]
9. The strictly conserved Arg-321 residue in the active site of Escherichia coli topoisomerase I plays a critical role in DNA rejoining. Narula G; Annamalai T; Aedo S; Cheng B; Sorokin E; Wong A; Tse-Dinh YC J Biol Chem; 2011 May; 286(21):18673-80. PubMed ID: 21478161 [TBL] [Abstract][Full Text] [Related]
10. The acidic triad conserved in type IA DNA topoisomerases is required for binding of Mg(II) and subsequent conformational change. Zhu CX; Tse-Dinh YC J Biol Chem; 2000 Feb; 275(8):5318-22. PubMed ID: 10681504 [TBL] [Abstract][Full Text] [Related]
11. New insights into DNA-binding by type IIA topoisomerases. Chang CC; Wang YR; Chen SF; Wu CC; Chan NL Curr Opin Struct Biol; 2013 Feb; 23(1):125-33. PubMed ID: 23265999 [TBL] [Abstract][Full Text] [Related]
12. Mutation adjacent to the active site tyrosine can enhance DNA cleavage and cell killing by the TOPRIM Gly to Ser mutant of bacterial topoisomerase I. Cheng B; Sorokin EP; Tse-Dinh YC Nucleic Acids Res; 2008 Feb; 36(3):1017-25. PubMed ID: 18096618 [TBL] [Abstract][Full Text] [Related]
13. Structure of DNA topoisomerases. Berger JM Biochim Biophys Acta; 1998 Oct; 1400(1-3):3-18. PubMed ID: 9748476 [TBL] [Abstract][Full Text] [Related]
14. Peptide sequencing and site-directed mutagenesis identify tyrosine-727 as the active site tyrosine of Saccharomyces cerevisiae DNA topoisomerase I. Lynn RM; Bjornsti MA; Caron PR; Wang JC Proc Natl Acad Sci U S A; 1989 May; 86(10):3559-63. PubMed ID: 2542938 [TBL] [Abstract][Full Text] [Related]
15. Mutagenesis of E477 or K505 in the B' domain of human topoisomerase II beta increases the requirement for magnesium ions during strand passage. West KL; Meczes EL; Thorn R; Turnbull RM; Marshall R; Austin CA Biochemistry; 2000 Feb; 39(6):1223-33. PubMed ID: 10684600 [TBL] [Abstract][Full Text] [Related]
16. Mutational analysis of vaccinia DNA topoisomerase defines amino acid residues essential for covalent catalysis. Wittschieben J; Shuman S J Biol Chem; 1994 Nov; 269(47):29978-83. PubMed ID: 7961997 [TBL] [Abstract][Full Text] [Related]
17. Intradimerically tethered DNA topoisomerase II is catalytically active in DNA transport. Lindsley JE Proc Natl Acad Sci U S A; 1996 Apr; 93(7):2975-80. PubMed ID: 8610153 [TBL] [Abstract][Full Text] [Related]
18. The hydrophilic, protease-sensitive terminal domains of eucaryotic DNA topoisomerases have essential intracellular functions. Shaiu WL; Hu T; Hsieh TS Pac Symp Biocomput; 1999; ():578-89. PubMed ID: 10380229 [TBL] [Abstract][Full Text] [Related]
19. Human small cell lung cancer NYH cells selected for resistance to the bisdioxopiperazine topoisomerase II catalytic inhibitor ICRF-187 demonstrate a functional R162Q mutation in the Walker A consensus ATP binding domain of the alpha isoform. Wessel I; Jensen LH; Jensen PB; Falck J; Rose A; Roerth M; Nitiss JL; Sehested M Cancer Res; 1999 Jul; 59(14):3442-50. PubMed ID: 10416608 [TBL] [Abstract][Full Text] [Related]
20. The purification and characterization of DNA topoisomerases I and II of the yeast Saccharomyces cerevisiae. Goto T; Laipis P; Wang JC J Biol Chem; 1984 Aug; 259(16):10422-9. PubMed ID: 6088500 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]